3-iodobenzylguanidine has been researched along with Leukocytopenia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beierwaltes, WH; Carey, JE; Copp, J; Glowniak, J; Mangner, T; Nakajo, M; Satterlee, W; Shapiro, B; Sisson, J; Swanson, DP | 1 |
Carey, JE; Hutchinson, RJ; Johnson, JW; Mallette, SA; Shapiro, B; Sisson, JC; Wieland, DM | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and Leukocytopenia
Article | Year |
---|---|
Treatment of malignant pheochromocytoma with a new radiopharmaceutical.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Cortex; Adult; Aged; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Leukopenia; Male; Middle Aged; Pheochromocytoma; Thyroid Gland | 1983 |
Toxicity from treatment of neuroblastoma with 131I-meta-iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adult; Child; Child, Preschool; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Leukopenia; Male; Neuroblastoma; Thrombocytopenia | 1988 |